These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 31871042)

  • 1. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical compatibility of pentoxifylline and intravenous medications.
    Senarathna SMDKG; Strunk T; Petrovski M; Batty KT
    Arch Dis Child; 2019 Mar; 104(3):292-295. PubMed ID: 30472662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physicochemical Stability and Sterility of Standard Parenteral Nutrition Solutions and Simulated Y-Site Admixtures for Neonates.
    Riera P; Garrido-Alejos G; Cardenete J; Moliner E; Zapico-Muñiz E; Cardona D; Garin N
    Nutr Clin Pract; 2018 Oct; 33(5):694-700. PubMed ID: 29464781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous pentoxifylline is well tolerated in critically ill preterm infants with sepsis or necrotizing enterocolitis.
    Schüller SS; Kempf K; Unterasinger L; Strunk T; Berger A
    Eur J Pediatr; 2020 Aug; 179(8):1325-1330. PubMed ID: 32179980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical compatibility of lipid emulsions and intravenous medications used in neonatal intensive care settings.
    Senarathna SMDKG; Strunk T; Petrovski M; Woodland S; Martinez J; Chuang VTG; Batty KT
    Eur J Hosp Pharm; 2023 Oct; ():. PubMed ID: 37875283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical compatibility of various drugs with neonatal total parenteral nutrient solution during simulated Y-site administration.
    Fox LM; Wilder AG; Foushee JA
    Am J Health Syst Pharm; 2013 Mar; 70(6):520-4. PubMed ID: 23456406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential benefits of pentoxifylline on wound healing.
    Ahmadi M; Khalili H
    Expert Rev Clin Pharmacol; 2016; 9(1):129-42. PubMed ID: 26558813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical and chemical compatibility of drotrecogin alfa (activated) with 34 drugs during simulated Y-site administration.
    Mann HJ; Demmon SL; Boelk DA; Payne CA; Effron MB; Rajagopalan N; Williams MD; Beck GM; Gopalrathnam G
    Am J Health Syst Pharm; 2004 Dec; 61(24):2664-71. PubMed ID: 15646701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical compatibility of tedizolid phosphate with selected i.v. drugs during simulated Y-site administration.
    Ghazi I; Hamada Y; Nicolau DP
    Am J Health Syst Pharm; 2016 Nov; 73(21):1769-1776. PubMed ID: 27769972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing.
    Ross EL; Salinas A; Petty K; Her C; Carpenter JF
    Am J Health Syst Pharm; 2020 Nov; 77(23):1980-1985. PubMed ID: 32974650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical compatibility of sulbactam/durlobactam with select intravenous drugs during simulated Y-site administration.
    Ruiz VH; Shen Y; Abouelhassan Y; Fouad A; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2024 Jan; 81(1):e21-e29. PubMed ID: 37740370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of compatibility of rhIGF-1/rhIGFBP-3 with neonatal intravenous medications.
    Salamat-Miller N; Turner MA; Bandekar A; Dixit N; Jochim E; Mangum B; McPherson C; Tenjarla S; Singh S; Hwang YS; Barton N
    World J Pediatr; 2023 Jan; 19(1):58-67. PubMed ID: 36344872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical compatibility of medications with concentrated neonatal and pediatric parenteral nutrition: A simulated Y-site drug compatibility study.
    Ross EL; Petty K; Salinas A; Her C; Carpenter JF
    JPEN J Parenter Enteral Nutr; 2023 Mar; 47(3):372-381. PubMed ID: 36582024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
    Campos-Baeta Y; Saavedra-Mitjans M; Garin N; Cardenete J; Cardona D; Riera P
    Nutr Clin Pract; 2020 Oct; 35(5):967-972. PubMed ID: 31482649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.
    Staven V; Wang S; Grønlie I; Tho I
    Nutr J; 2016 Mar; 15():29. PubMed ID: 27000057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of drug infusions in the NICU.
    Kalikstad B; Skjerdal A; Hansen TW
    Arch Dis Child; 2010 Sep; 95(9):745-8. PubMed ID: 20570841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
    Trissel LA; Saenz CA; Ogundele AB; Ingram DS
    Am J Health Syst Pharm; 2004 Nov; 61(21):2289-93. PubMed ID: 15552637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraarterial pulmonary pentoxifylline improves cardiac performance and oxygen utilization after hemorrhagic shock: a novel resuscitation strategy.
    Coimbra R; Razuk-Filho A; Yada-Langui MM; Rocha-E-Silva M
    Anesth Analg; 2004 May; 98(5):1439-46, table of contents. PubMed ID: 15105227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.